These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 3368192)
1. Significance of serum phosphohexose isomerase in gastrointestinal cancer at different stages. Baumann M; Brand K; Giedl J; Hermanek P; Ruf S; Scheele J; Hoferichter S; Gall FP Oncology; 1988; 45(3):153-8. PubMed ID: 3368192 [TBL] [Abstract][Full Text] [Related]
2. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. Baumann M; Kappl A; Lang T; Brand K; Siegfried W; Paterok E Cancer Invest; 1990; 8(3-4):351-6. PubMed ID: 2207761 [TBL] [Abstract][Full Text] [Related]
3. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients. Paulick R; Caffier H; Paulick M Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of different serum tumor markers in gynecological malignancies. Paulick R; Caffier H; Horner G; Lang K; Filbry E Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031 [TBL] [Abstract][Full Text] [Related]
5. Serum tumor markers in metastatic breast cancer and course of disease. Caffier H; Brandau H Cancer Detect Prev; 1983; 6(4-5):451-7. PubMed ID: 6197167 [TBL] [Abstract][Full Text] [Related]
6. Phosphohexose isomerase and carcinoembryonic antigen in the sera of patients with primary lung cancer. Santabárbara P; Molina R; Estapé J; Ballesta AM Int J Biol Markers; 1988; 3(2):113-22. PubMed ID: 3243977 [TBL] [Abstract][Full Text] [Related]
7. Specificity of carcinoembryonic antigen, gastrointestinal cancer-associated antigen, tissue polypeptide antigen, fibrinopeptide A and gamma-glutamyltransferase in the diagnosis and follow-up of gastric cancer. Abbasciano V; Levato F; Zavagli G Oncology; 1988; 45(3):159-61. PubMed ID: 2897101 [TBL] [Abstract][Full Text] [Related]
8. [Value of CA 125 in comparison to conventional tumor markers in ovarian cancer]. Paulick R; Kaesemann H; Caffier H Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):509-14. PubMed ID: 2875919 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences. Barillari P; Sammartino P; Cardi M; Ricci M; Gozzo P; Cesareo S; Cerasi A Aust N Z J Surg; 1991 Sep; 61(9):675-80. PubMed ID: 1877936 [TBL] [Abstract][Full Text] [Related]
10. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer. Patel PS; Raval GN; Rawal RM; Patel GH; Balar DB; Shah PM; Patel DD Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208 [TBL] [Abstract][Full Text] [Related]
11. Serum phosphohexose isomerase activities in patients with colorectal cancer. Filella X; Molina R; Jo J; Mas E; Ballesta AM Tumour Biol; 1991; 12(6):360-7. PubMed ID: 1798910 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of six tumor markers in patients with prostatic carcinoma and bladder tumors. Schwemmer B; Schütz W; Kuntz RM; Lehmer A Urol Res; 1985; 13(3):133-6. PubMed ID: 4024395 [TBL] [Abstract][Full Text] [Related]
13. Phosphohexose isomerase in hypernephroma. Significance as serum tumor marker, comparison to other glycolytic enzymes and isozyme patterns in normal and tumor tissue. Baumann M; Lang T; Brand K Urol Res; 1988; 16(5):345-9. PubMed ID: 3201649 [TBL] [Abstract][Full Text] [Related]
14. [Combination of cancer markers in the detection and prognosis of digestive system tumors]. de Mello Júnior JP; Giles GR Arq Gastroenterol; 1986; 23(3):133-44. PubMed ID: 2449153 [TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen and phosphohexose isomerase, gammaglutamyl transpeptidase and lactate dehydorgenase levels in patients with and without liver metastases. Munjal D; Chawla PL; Lokich JJ; Zamcheck N Cancer; 1976 Apr; 37(4):1800-7. PubMed ID: 4219 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients. Yasasever V; Dinçer M; Camlica H; Duranyildiz D; Dalay N Eur J Gynaecol Oncol; 1997; 18(5):397-9. PubMed ID: 9378161 [TBL] [Abstract][Full Text] [Related]
17. [Experience in the use of the tumor markers CEA, GICA and TPA in the postoperative monitoring of colorectal neoplasms]. Morelli M; Nardi M; Valle M; Balducci D; Serafini D; Bernardini P Minerva Med; 1985 Sep; 76(34-35):1529-31. PubMed ID: 2412188 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of six tumor markers in patients with benign and malignant gynecological disease. Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sato T; Takamizawa H; Wiklund B Arch Gynecol Obstet; 1988; 243(2):61-8. PubMed ID: 3401042 [TBL] [Abstract][Full Text] [Related]
19. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer. Lee YC; Yang PC; Kuo SH; Luh KT J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012 [TBL] [Abstract][Full Text] [Related]
20. CA 15-3 in human breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA). Caponigro F; Iaffaioli RV; Pagliarulo C; De Placido S; Frasci G; Ungaro B; Matano E; Bianco AR Int J Biol Markers; 1990; 5(2):73-6. PubMed ID: 2283480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]